NOV 17, 2016 7:00 AM PST

From heart to mind: Simplified iPS cell reprogramming into cardiac and neural cells under hypoxic conditions

Sponsored by: Eppendorf, Eppendorf
Speaker

Abstract
DATE: November 17, 2016
TIME: 7:00am PT, 10:00am ET

Induced pluripotent stem (iPS) cell reprogramming allows turning an adult somatic cell into a pluripotent stem cell. Four Factor pluripotency reprogramming of somatic cells and subsequent multi-lineage directed differentiation can be accomplished by robust genetically modifying/manipulating methods. More recently non-genetically modifying methods for induction have gained popularity as they lend themselves to translational and clinically related research paradigms. 

In this study we developed an optimized single Episomal vector bearing multiple interspersed genes. This single entity plasmid electroporated into fibroblasts and cultured in low oxygen tension (4%O2) with optimized xeno-free media and accompanying small molecule mixtures leads to reproducible reprogramming. Simplifications of xeno-free neuronal and cardiac differentiation methods rely on a 2 step procedure. Differentiated neuronal cells become TH+/MAP2+, and secrete dopamine as measured by HPLC and differentiated cardiac cell leads to efficient appearance of beating clusters within 8-10 days of initiating the protocol. In order to ready methods for translational and clinical type research, the goal of the study presented here was to optimize the culturing atmosphere, and simplify the regimen of medias, growth factors, and small molecules that will streamline multiple differentiation pathways.


Learning Objectives:
  • Obtain an overview of somatic cell reprogramming methods
  • Learn about episomal repogramming methodology and its advantages
  • Learn how to differentiate induced pluripotent cells into neurons and functional cardiomyocytes
  • Gain insights into improving efficiency of cellular reprogramming by optimizing culture atmosphere, media, growth factors and small molecules

Show Resources
You May Also Like
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
SEP 28, 2022 7:00 AM PDT
SEP 28, 2022 7:00 AM PDT
Date: September 28, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) CRISPR/Cas gene editing technology has rapidly evolved over the last decade. Its versatility extends from creating t...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
Loading Comments...
Show Resources